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Abstract
Background: A decoction comprised of Nigella sativa seeds, Hemidesmus indicus root and Smilax
glabra  rhizome is used to treat cancer patients in Sri Lanka. However, the anti-carcinogenic
properties of this decoction have not been experimentally confirmed. The purpose of this study
was to determine whether the above decoction could protect against chemically induce
hepatocarcinogenesis.
Methods:  The effects of this decoction on diethylnitrosamine (DEN) induced
hepatocarcinogenesis were examined in male Wistar rats using the medium term bioassay system
of Ito, based on a 2-step model of hepatocarcinogenesis. Rats were randomly divided into 6 groups
of 10 each. Groups 1 to 4 were injected with DEN (200 mg/kg) to initiate carcinogenesis. Twenty-
four hours later groups 1 and 2 were administered the decoction at 4 g/kg body weight/day (dose
1) and 6 g/kg body weight/day (dose 2), respectively. Group 3 and group 4 were given distilled
water instead of the decoction and a suspension of garlic powder (20 g/kg body weight/day) in
distilled water (positive control), respectively. Group 5 and 6 were injected with normal saline and
twenty-four hours later group 5 was given distilled water (normal control) while group 6 was given
decoction dose 2 (decoction control). Oral feeding continued for two weeks after which all rats
were subjected to 2/3 partial hepatectomy to promote carcinogenesis. Oral feeding continued for
eight more weeks. At the end of the 10th week, rats were sacrificed and samples of livers taken
for immunohistochemical studies.
Carcinogenic potential was scored by comparing the number, area and staining intensity of
glutathione S-transferase placental form (GST-P) positive foci and the number of cells/cm2 of the
positive foci in the livers of the six groups of rats.
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Results: The number and area of DEN-mediated GST-P positive foci, number of cells/cm2 of foci
and staining intensity of the foci were significantly (P > 0.001) reduced by the decoction and garlic
in the order dose 2 = garlic >dose 1.
Conclusion: Overall results indicate that the decoction comprised of N. sativa, S. glabra and H.
indicus has the potential to protect rat liver against DEN induced hepatocarcinogenesis
Background
Cancer has become an important topic in medicine since
it is a major cause of death in both the developed and
developing countries and it is now only secondary to that
of myocardial infarction [1]. A great majority of human
cancers (about 80%-90%) are attributable to environ-
mental factors [2]. However, it is not an easy task to elim-
inate carcinogenic causes from the environment. While
modern surgery has significantly reduced the cancer mor-
tality, the use of additional treatment such as radiotherapy
and chemotherapy has resulted in no more than 5%
reduction in the number of deaths [2]. Therefore, there is
a continuing search for better control and preventive
methods in order to reduce cancer mortality and related
side effects. Many investigations are now being carried out
to discover naturally occurring compounds, which can
suppress or prevent the process of carcinogenesis [3–6].
A herbal remedy that has been developed from ancient
Ola leaf inscription and prescribed to cancer patients (per-
sonal communication, Ayurvedic physician, Dr. N. Jayat-
hilake) contains Nigella sativa (seeds), Hemidesmus indicus
(root) and Smilax glabra (rhizome). Although, this plant
mixture in the form of a decoction has been prescribed to
cancer patients for so many years, it has, to date, not been
subjected to any form of scientifically controlled investi-
gation to determine if this herbal formulation truly has
the potential to be of benefit to these patients. Tradition-
ally, all the three plant types used in the formulation of
this decoction are considered useful in the preparation of
medications used in the treatment of boils and other skin
conditions [7].
Glutathione S-transferase, a detoxifying enzyme in the
liver has many isoforms. In adult rats, the GST-P form is
strongly expressed during the early stage of chemically
induced hepatocarcinogenesis. Previous investigators
have demonstrated that garlic could significantly protect
against diethylnitrosamine (DEN) induced expression of
GST-P in rat livers [5]. No records can be found in pub-
lished literature regarding the use of a decoction contain-
ing Nigella sativa, Hemidesmus indicus and Smilax glabra for
the specific treatment of cancer patients. In view of this
and the increasing global incidence of cancer [1], an inves-
tigation of the anti-tumor potential of this decoction was
considered important.
Investigations have therefore been initiated to determine
the ability of the decoction comprised of Nigella sativa
(seeds), Hemidesmus indicus (root) and Smilax glabra (rhi-
zome) to protect against DEN-induced hepatocarcinogen-
esis. In the present study, the anti-carcinogenic potential
was assessed by its effects on DEN-mediated GST-P
expression in rat liver.
Methods
Experimental animals
In all experiments Wistar rats (8 week old littermates, 190
± 10 g) were used and maintained in a temperature con-
trolled room (25°C ± 2°C) under 12 hours light/dark
cycle (dark phase 6 p.m. to 6 a.m.).
Rats were fed with a standard laboratory diet containing
19% crude proteins, 3.8% fiber and 4400 kcal of energy,
prepared by the Medical Research Institute, Sri Lanka,
based on a formula recommended by the WHO and water
ad libitum [8].
Plant material
Dried rhizome of Smilax glabra, dried seed of Nigella sativa
and dried root of Hemidesmus indicus were purchased
locally, and identities were confirmed by Botanist,
Bandaranayake Memorial Ayurveda Research Institute,
Navinna, Maharagama, Sri Lanka. Garlic bulbs were oven
dried at 60°C and powdered (kindly supplied by Aushada
Lanka (Pvt) Ltd, Colombo 03, Sri Lanka).
Chemicals
Diethylnitrosamine (DEN) and Diaminobenzidine
(DAB) were purchased from Sigma Diagnostics Inc, USA.
Normal Swine serum, Rabbit polyclonal anti GST-P anti-
body, Biotin labeled anti Rabbit IgG and. Avidin Biotin-
peroxidase Complex (ABC) were purchased from DAKO,
Denmark.
Preparation of the decoction
The plant decoction was prepared according to the
method recommended by traditional Medical practition-
ers for the administration to cancer patients (Personal
communication, Dr. N. Jayathilake, Bandaranayake
Memorial Ayurvedic Research Institute, Navinna, Maha-
ragama, Sri Lanka).Journal of Carcinogenesis 2003, 2 http://www.Carcinogenesis.com/content/2/1/6
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20 g each of Nigella sativa (seeds),  Hemidesmus indicus
(root) and Smilax glabra (rhizome) were mixed and boiled
in 1.6 l of distilled water and final volume was reduced to
200 ml by boiling over 3 hours.
Dosage and administration of decoction
The decoction was administered to rats using a Sondi nee-
dle by gastric gavage method. The effect of two doses of
the decoction was studied. Dose 1 was 4 g/kg-body
weight/day. This dose corresponded to normal therapeu-
tic dose administered to adult humans as calculated based
on relative surface areas of human and rat. Dose 2 pro-
vides a higher dose of 6 g decoction/-kg body weight/day.
Experimental procedure
Sixty male Wistar rats were randomly divided into 6
groups of 10 animals in each group (groups 1–6). Groups
1 and 2 served as the test groups to which the two doses
of the decoction under investigation were administered.
Animals in these two groups were injected with a single
dose of DEN dissolved in normal saline (200 mg/kg-body
weight) to initiate hepatocarcinogenesis [9]. Twenty-four
hours later, the animals were orally administered the
decoction at doses of 4 g/kg/day (group 1) and 6 g/kg/day
(group 2) respectively.
The decoction treatment was continued for two weeks
after which the animals were subjected to two-third par-
tial-hepatectomy (PH) by the technique recommended by
Higgins and Anderson [10] for the promotion of hepato-
carcinogenesis. Treatment with the respective doses of the
decoction was then continued for six more weeks. Groups
3 (DEN control) and 4 (positive control) were treated
with DEN and subjected to partial hepatectomy in the
same manner as groups 1 and 2. However, instead of the
decoction, animals in-group 3 were orally administered
distilled water, while those in group 4 received a dose of
garlic (20 mg/kg/day) that had previously been shown to
protect against DEN induced hepatocarcinogenesis in rats
[5].
Groups 5 and 6 (negative control and decoction control)
animals received saline (i.p) instead of DEN and sub-
jected to PH after 2 weeks. In place of the decoction, ani-
mals in-group 5 received only distilled water, for the same
time period as all the other animals. Rats in each group
were sacrificed for examination after 8 weeks. Weights of
rats in each group were recorded at the beginning of the
experiment and at the end of every week.
Tissue processing
At autopsy, livers were excised and slices of 2–3 mm thick
(six slices of liver, two each from the right posterior, right
anterior and caudate lobes) were cut with a surgical blade,
fixed in 10% phosphate buffered formalin and embedded
in paraffin. They were used for immunohistochemical
examination of GST-P positive foci.
GST-P immunohistochemistry
The Avidin Biotin peroxidase Complex (ABC) method
described by Hsu et al [11] was used to demonstrate GST-
P liver foci. Deparaffinized sections were treated with nor-
mal swine serum (1:10), rabbit polyclonal anti GST-P
antibody (1:150), biotin labeled anti rabbit IgG (1:300)
and ABC. The sites of peroxidase binding were visualized
using Diaminobenzidine (DAB) method [11]. Sections
were counter stained with Carazzis Haematoxylin for
microscopic examination. As positive control for the
specifity of anti-GST-P antibody binding human thyroid
sections were used. The number of foci, number of cells in
each focus, total area of the liver sections, area of GST-P
positive foci and staining intensity of each focus were
measured using an OLYMPUS research microscope
(X400).
Statistical analysis
The results were expressed as Mean ± Standard Error of
Mean (S.E.M). The significance of difference in the
number of foci, area of foci, number of cells and staining
intensity between the control 1 and test groups were ana-
lyzed by Student's t-test.
Results
In this study, "the modified method of the medium term
bioassay system" of Ito based on the two-step model of
hepatocarcinogenesis was used as an assay system [10].
This system was initially introduced in order to screen
environmental and naturally-occurring carcinogens.
However, it was later used successfully for identifying dif-
ferent anti carcinogens [12,13]. DEN was used as a carcin-
ogen to initiate hepatocarcinogenesis because it is a
proven and specific carcinogen for hepatocarcinogenesis
[14].
The protective actions of the decoction treatment on
hepatocarcinogenesis induced by DEN are summarized in
Tables 1 and 2. The effects of the decoction have also been
compared with those produced by a dose of garlic which
had in a previous study [5] been shown to significantly
protect against DEN-induced hepatocarcinogenesis of
Wistar rats. From the results in Table 1, it is evident that
the animals treated with the decoction dose 2, shows a sig-
nificant reduction in GST-P positive foci number, foci area
and number of cells/cm2 of foci when compared to those
treated with DEN and distilled water (group 3). The effects
produced by the decoction dose 2 were very similar to
those produced by garlic. In the test groups (groups 1 and
2), the number of positive cells /cm2 of foci reduced by
71.4%in test 1 and 83.8% in test 2 when compared with
those of group 3. The reduction in the garlic treated groupJournal of Carcinogenesis 2003, 2 http://www.Carcinogenesis.com/content/2/1/6
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was 83.3%. Results in Table 2 demonstrate that in animals
treated with decoction dose 1 and 2, there was a marked
reduction in staining intensity of cells when compared to
group 3 animals treated with DEN and distilled water.
There was no significant difference between the final body
weights of the control rats and the rats treated with the
decoction or garlic.
Discussion
Rat GST-P, which is related to human GST-π in enzymatic
and immunological properties, is used by many research-
ers as a reliable marker for preneoplastic lesions, since it is
strongly and specifically expressed in the very early phase
of chemically induced hepatocarcinogenesis, but not in
normal hepatocytes [14]. The degree of induction of GST-
P positive foci and nodules in this bioassay system for
hepatocarcinogenesis has been proven to correspond with
incidence of hepatocellular carcinomas observed in long-
term in vivo assays [15,16].
In the present investigation it was observed that that
decoction comprised of Nigella sativa (seeds), Hemidesmus
indicus  (root) and Smilax glabra (rhizome) can signifi-
cantly inhibit DEN-mediated GST-P expression in rat liv-
ers. Previous investigation by Samaranayake et al., (2000)
has shown that garlic at a dose of 20 g/kg body weight /
day can significantly inhibit DEN-mediated GST-P expres-
sion in rat livers. It is interesting to note that the altera-
tions in DEN-induced changes in the hepatocytes
mediated by dose 2 of the decoction were very similar to
those produced by garlic at a dose of 20 mg/kg body
weight/day.
The overall results obtained in the present study indicate
that the decoction under investigation, which was pre-
pared from N. sativa seed, S. glabra rhizome and H. indicus
root has the potential to inhibit the early DEN initiated
phase of hepatocarcinogenesis. Pre cancerous inhibition
by the decoction may be taking place after initiation with
DEN, after promotion by partial hepatectomy, or during
both stages of carcinogenesis. Further studies are required
to determine exactly at what stage the inhibition takes
place.
The mechanism by which the decoction mediates its anti-
carcinogenic effects is not clear. Anti-tumor effect of the
decoction may be mediated by one or more of the follow-
ing mechanisms:
(a) detoxification of the carcinogen by inducing detoxifi-
cation enzymes such as GSTs.
Table I: Numbers and areas of DEN-initiated GST-P positive foci in the livers of rats treated with decoction or garlic.
Group Treatment Foci/cm2 Area mm2 / cm2 Cells/cm2
Test 1 DEN+ Decoction dose 1 16.0 ± 9.2* 0.09 ± 0.01* 121.2 ± 31.5*
Test 2 DEN+Decoction Dose 2 5.3 ± 1.8** 0.07 ± 0.01** 68.5 ± 24.7**
Control 1 DEN+Distilled water 24.4 ± 3.9 0.37 ± 0.03 424.2 ± 77.4
Control 2 (Positive control) DEN+Garlic 5.3 ± 2.6** 0.16 ± 0.04** 70.8 ± 29.1**
Control 3 (Negative control) Saline+Distilled water 3.2 ± 2.1 0.02 ± 0.01 33.1 ± 25.2
Control 4 (Decoction control) Saline+ Decoction dose 2 ND ND ND
Data shown are the Mean ± SEM of 10 determinations * Significantly different from control 1 at P < 0.01 (student's t test) ** Significantly different 
from control 1at P < 0.001 (student's t test) ND – Not Detected
Table 2: Staining intensity of DEN-induced liver GST-P positive foci in Wistar rats treated with decoction or garlic.
Group Treatment ++++% +++% ++% +% Positive foci not detected%
Test 1 DEN+Decoction Dose 1 ND 4.3* 21.7 21.7 52.2*
Test 2 DEN+Decoction Dose 2 ND ND 16.7 16.7 58.3*
Control 1 DEN+Distilled water 21.4 42.9 14.3 21.4 ND
Control 2 DEN+garlic ND ND 25.0 25.0 50.0*
Control 3 Saline+Distilled Water ND ND ND 36.4 63.6
Control 4 Saline+Decoction Dose 2 ND ND ND ND ND
Data shown are the percentage values of 10 determinations ++++: very strongly stained foci +++ :strongly stained foci ++ :moderately stained foci 
+ :weakly stained foci ND : Not DetectedJournal of Carcinogenesis 2003, 2 http://www.Carcinogenesis.com/content/2/1/6
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(b) anti-oxidant activity.
(c) immuno modulatory action.
(d) cytotoxicity.
Recent in vitro studies have demonstrated that N. sativa
can be cytotoxic to several cancer cell lines [17]. Thymo-
quinone and dithymoquinone, two isolated active com-
ponents of N. sativa, have also been shown to be cytotoxic
to several parental and multi drug resistant (MDR) human
cell lines [18]. Further Nigella sativa and Hemidesmus indi-
cus  have been shown to possess anti-oxidant activities
[19–22].
Investigations on the mechanisms of action of the decoc-
tion used in the present study is in progress. Anti-carcino-
genic effect of the extracts of individual plants in the
decoction was not studied because only the decoction
comprised of N. sativa seed, S. glabra rhizome and H. indi-
cus root is traditionally used in cancer therapy. Recent in
vivo studies have shown that tumour development in mice
skin could be inhibited by the active principles of Nigella
sativa [17,23]. Whether Nigella sativa is mainly responsible
or all the three plants are equally responsible for the anti-
tumor potential demonstrated by the decoction in the
present study is not clear and further studies are required
before definite conclusions can be reached.
Conclusion
It can be concluded from the study that the decoction
under investigation can protect the liver against chemi-





WHO: World Health Organization
DAB: Diaminobenzidine
ABC: Avidin Biotin-peroxidase Complex
PH: Partial-Hepatectomy
S.E.M: Standard Error of Mean
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